Join us for SAE Media Group's 2nd Annual RNA Therapeutics USA Conference on October 23-24, 2024, at Courtyard by Marriott Boston Downtown.
RNA therapies are at the forefront of genetic medicine, with the market projected to reach $1.81 billion by 2025. Explore mRNA vaccine advancements and regulatory successes shaping the field.
Discover the latest challenges and advancements in RNA delivery, particularly targeting the Central Nervous System. Uncover how RNA technologies are revolutionizing immunotherapies and vaccines, offering new hope for previously untreatable diseases.
Network with global experts from pharma and biotech, including Directors of RNA therapies, CEOs, scientists, and medical officers. Don't miss this opportunity to drive innovation in RNA therapeutics!
URL:
Brochure: https://go.evvnt.com/2446062-2?pid=263
Price:
RNA Therapeutics USA (EARLY BIRD DISCOUNT UNTIL 09/06/24): USD 2399.00
Speakers: CHELSEA THORN - Senior Scientist, Pfizer, CONFIRMED REPRESENTATIVE - BioPhorum, DEREK O HAGAN - Senior Advisor R and D, GSK, HEINRICH HAAS - Chief Technology Officer, NeoVac, HETAL PATEL - Senior Principle Scientist/Group Leader, Pfizer, JAY SARKAR - Researcher and Entrepreneur, Stanford University, JIM WETERINGS - Vice President R and D USA RNA Therapeutics and Delivery, Sirnaomics, KINKINI ROY - Associate Director, Aviceda Therapeutics, MARTIN AKERMAN - CTO and Co-Founder, Envisagenics, NEIL ROBERTSON - Principal Scientist, TransCode Therapeutics, Inc., RICHARD GEARY - EVP, Chief Development Officer, Ionis Pharmaceuticals, Inc., SOURAV CHOUDHURY - Head AAV Technologies, Sanofi, STEVE PASCOLO - Founder and CEO, Miescher Pharma GmbH, YUE HUI - Scientist, Moderna, ZIMENG WANG - Senior Scientist, AstraZeneca
RNA therapies are at the forefront of genetic medicine, with the market projected to reach $1.81 billion by 2025. Explore mRNA vaccine advancements and regulatory successes shaping the field.
Discover the latest challenges and advancements in RNA delivery, particularly targeting the Central Nervous System. Uncover how RNA technologies are revolutionizing immunotherapies and vaccines, offering new hope for previously untreatable diseases.
Network with global experts from pharma and biotech, including Directors of RNA therapies, CEOs, scientists, and medical officers. Don't miss this opportunity to drive innovation in RNA therapeutics!
URL:
Brochure: https://go.evvnt.com/2446062-2?pid=263
Price:
RNA Therapeutics USA (EARLY BIRD DISCOUNT UNTIL 09/06/24): USD 2399.00
Speakers: CHELSEA THORN - Senior Scientist, Pfizer, CONFIRMED REPRESENTATIVE - BioPhorum, DEREK O HAGAN - Senior Advisor R and D, GSK, HEINRICH HAAS - Chief Technology Officer, NeoVac, HETAL PATEL - Senior Principle Scientist/Group Leader, Pfizer, JAY SARKAR - Researcher and Entrepreneur, Stanford University, JIM WETERINGS - Vice President R and D USA RNA Therapeutics and Delivery, Sirnaomics, KINKINI ROY - Associate Director, Aviceda Therapeutics, MARTIN AKERMAN - CTO and Co-Founder, Envisagenics, NEIL ROBERTSON - Principal Scientist, TransCode Therapeutics, Inc., RICHARD GEARY - EVP, Chief Development Officer, Ionis Pharmaceuticals, Inc., SOURAV CHOUDHURY - Head AAV Technologies, Sanofi, STEVE PASCOLO - Founder and CEO, Miescher Pharma GmbH, YUE HUI - Scientist, Moderna, ZIMENG WANG - Senior Scientist, AstraZeneca
